Cart
sales@molnova.com
Phosphorylase Kinase b-Subunit Fragment (420-436)
CAS No. ———
Phosphorylase Kinase b-Subunit Fragment (420-436)( ——— )
Catalog No. M41242 CAS No. ———
Phosphorylase Kinase b-Subunit Fragment (420-436)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhosphorylase Kinase b-Subunit Fragment (420-436)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhosphorylase Kinase b-Subunit Fragment (420-436)
-
DescriptionPhosphorylase Kinase b-Subunit Fragment (420-436)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1946.2
-
Molecular FormulaC79H130N31O25S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Remimazolam Tosilate...
Remimazolam Tosilate is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam.
-
pp60 c-src (521-533)...
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain; phosphorylated at Tyr527. Binds to pp60c-src and pp60v-src at the SH2 domain, suppressing their tyrosine kinase activity and transforming potential.
-
Ciraparantag acetate
Ciraparantag acetate, an anticoagulant reversal agent, is a small molecule specifically designed to bind noncovalently by charge-charge interaction to unfractionated heparin and low-molecular-weight heparin.?
